SCHEMBL5650848

SCHEMBL5650848

CC1(c2ccccc2)C(=O)N(Cc2ccc3ccc(C=NN)cc3c2)C(=O)N1Cc1cccc(C(N)=O)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTRB1 P17538 1/20 0.39
OPRM1 P35372 8/20 0.37
OPRK1 P41145 6/20 0.37
OPRL1 P41146 2/20 0.36
BRD4 O60885 1/20 0.35
OPRD1 P41143 4/20 0.35
KMT2A Q03164 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
HPGD P15428 1/20 0.35
RAB9A P51151 1/20 0.35
PTPN1 P18031 2/20 0.34
ACP1 P24666 2/20 0.34
PARG Q86W56 1/20 0.33
PLA2G10 O15496 1/20 0.33
FNTA P49354 1/20 0.33
FNTB P49356 1/20 0.33
FABP4 P15090 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5652364 0.97 CTRB1 (0.39) CTRB1OPRM1OPRK1OPRL1BRD4
Trifluoroacetic Acid SCHEMBL5649098 0.95 CTRB1 (0.36) CTRB1OPRM1OPRK1OPRL1BRD4
SCHEMBL5648162 0.94 KMT2A (0.41) KMT2AKDM4EALDH1A1PTPN1ACP1
SCHEMBL5648086 0.93 CTRB1 (0.40) CTRB1OPRM1OPRK1OPRL1KMT2A
SCHEMBL5645171 0.93 CTRB1 (0.40) CTRB1OPRM1OPRL1KMT2AKDM4E
SCHEMBL5650573 0.91 TRPA1 (0.42) OPRM1OPRD1KMT2AKDM4EMEN1
SCHEMBL5648228 0.91 PTPN1 (0.40) KMT2AMEN1HPGDPTPN1ACP1
SCHEMBL5649247 0.89 PTPN1 (0.44) CTRB1KMT2AMEN1HPGDPTPN1
SCHEMBL5647820 0.88 PTPN1 (0.44) CTRB1KMT2AMEN1HPGDPTPN1
SCHEMBL5645241 0.87 KMT2A (0.36) CTRB1OPRL1KMT2AKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060142363-A1 Imidazolidinedione analogs useful as anticoagulants and antithrombotics SCHERING AKTIENGESELLSCHAFT (DE) 2006-06-29 US claimed
US-7053112-B2 Imidazolidinedione analogs useful as anticoagulants and antithrombotics SCHERING AKTIENGESELLSCHAFT (DE) 2006-05-30 US claimed
US-20040122073-A1 Imidazolidinedione analogs useful as anticoagulants and antihrombotics SCHERING AKTIENGESELLSCHAFT (DE) 2004-06-24 US claimed
US-7199146-B2 Imidazolidinedione analogs useful as anticoagulants and antithrombotics SCHERING AKTIENGESELLSCHAFT (DE) 2007-04-03 US disclosed
US-20060142363-A1 Imidazolidinedione analogs useful as anticoagulants and antithrombotics SCHERING AKTIENGESELLSCHAFT (DE) 2006-06-29 US disclosed
US-7053112-B2 Imidazolidinedione analogs useful as anticoagulants and antithrombotics SCHERING AKTIENGESELLSCHAFT (DE) 2006-05-30 US disclosed
US-20040122073-A1 Imidazolidinedione analogs useful as anticoagulants and antihrombotics SCHERING AKTIENGESELLSCHAFT (DE) 2004-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122073-A1 Imidazolidinedione analogs useful as anticoagulants and antihrombotics SERPINC1, F2, BDKRB1 CTRB1 259/4885OPRM1 2050/4885OPRK1 1479/4885
US-20060142363-A1 Imidazolidinedione analogs useful as anticoagulants and antithrombotics SERPINC1, F2, BDKRB1 CTRB1 208/4885OPRM1 3580/4885OPRK1 2472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.